Кэролайн Криадо Перес - Невидимые женщины [Почему мы живем в мире, удобном только для мужчин. Неравноправие, основанное на данных] [litres]
- Название:Невидимые женщины [Почему мы живем в мире, удобном только для мужчин. Неравноправие, основанное на данных] [litres]
- Автор:
- Жанр:
- Издательство:Литагент Альпина
- Год:2020
- Город:Москва
- ISBN:978-5-9614-3871-0
- Рейтинг:
- Избранное:Добавить в избранное
-
Отзывы:
-
Ваша оценка:
Кэролайн Криадо Перес - Невидимые женщины [Почему мы живем в мире, удобном только для мужчин. Неравноправие, основанное на данных] [litres] краткое содержание
Кэролайн Криадо Перес вскрывает в книге серьезную проблему, напрямую влияющую на здоровье и благополучие женщин: разработчики различных продуктов и технологий опираются на данные, собранные о человеке, где «человек» по умолчанию «мужчина». Женщины же с их особенностями и потребностями остаются незамеченными. Автор обходит стороной глубокие дебаты о природе современного феминизма, но представляет бесспорные факты дефицита гендерных данных в самых разных областях – от политики и медицинских исследований до технологий, трудовых отношений, планирования городского пространства и медиа.
Эта блестящая книга, получившая множество престижных наград, доказывает необходимость перемен и заставляет взглянуть на устройство нашего мира по-новому.
Невидимые женщины [Почему мы живем в мире, удобном только для мужчин. Неравноправие, основанное на данных] [litres] - читать онлайн бесплатно ознакомительный отрывок
Интервал:
Закладка:
895
Gender and Health Knowledge Agenda’, May 2015 (ZonMw, Netherlands).
896
https://theconversation.com/medicines-gender-revolution-how-womenstopped-being-treated-as-small-men-77171.
897
https://orwh.od.nih.gov/clinical/women-and-minorities/.
898
https://orwh.od.nih.gov/sites/orwh/files/docs/NOT-OD-15-102_Guidance.pdf.
899
Yoon et al. (2014).
900
Канадские институты медицинских исследований (Canadian Institutes of Health Research, CIHR) – финансируемый государством орган, занимающийся поддержкой исследований и инноваций в области здравоохранения.
901
Rees, Teresa (2011), ‘The Gendered Construction of Scientific Excellence’, Interdisciplinary Science Reviews , 36:2, 133–45.
902
Howard, Ehrlich, Gamlen and Oram (2017).
903
Holdcroft (2007).
904
Там же.
905
Marts and Keitt (2004).
906
http://www.nature.com/news/infections-reveal-inequality-between-the-sexes-1.20131?WT.mc_id=TWT_NatureNews.
907
Ortona, Delunardo, Baggio and Malorni (2016).
908
http://www.goretro.com/2014/08/mothers-little-helper-vintage-drug-ads.html.
909
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC198535/.
910
Там же.
911
Gender and Health Knowledge Agenda’, May 2015 (ZonMw, Netherlands).
912
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC198535.
913
Там же.
914
Там же.
915
http://www.ajmc.com/newsroom/women-taking-stains-faced-increased-diabetes-risk.
916
https://www.health.harvard.edu/heart-health/gender-matters-heart-disease-risk-in-women.
917
Pollitzer (2013).
918
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4800017/.
919
Whitley and Lindsey (2009).
920
https://www.washingtonpost.com/news/wonk/wp/2014/06/07/bad-medicine-the-awful-drug-reactions-americans-report/?utm_term=.1a7067d-40dce.
921
Tharpe, N. (2011), ‘Adverse Drug Reactions in Women’s Health Care’, Journal of Midwifery & Women’s Health , 56, 205–13.
922
https://www.washingtonpost.com/news/wonk/wp/2014/06/07/bad-medicine-the-awful-drug-reactions-americans-report/?utm_term=.1a7067d-40dce.
923
Marts and Keitt (2004).
924
Carey, Jennifer L. et al. (2017), ‘Drugs and Medical Devices: Adverse Events and the Impact on Women’s Health’, Clinical Therapeutics , 39:1.
925
Yoon et al. (2014).
926
‘Gender and Health Knowledge Agenda’, May 2015 (ZonMw, Netherlands) 134 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC198535/.
927
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC198535/.
928
https://www.hindawi.com/journals/bmri/2011/187103/.
929
Там же.
930
Anderson (2005).
931
Wang, Lishi et al. (2017), ‘Sex Differences in Hazard Ratio During Drug Treatment of Non-small-cell Lung Cancer in Major Clinical Trials: A Focused Data Review and Meta-analysis’, Clinical Therapeutics , 39:1.
932
Ibarra, Vazquez and Fagiolino (2017).
933
Whitley and Lindsey (2009).
934
Там же.
935
Там же.
936
https://www.georgeinstitute.org/media-releases/disadvantaged-womenat-greater-risk-of-heart-disease-than-men-0.
937
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4800017/; http://circ.ahajournals.org/content/133/9/916?sid=beb5f268-4205-4e62-be8f-3caec4c4d9b7.
938
http://heart.bmj.com/content/102/14/1142.
939
http://circ.ahajournals.org/content/133/9/916?sid=beb5f268-4205-4e62-be8f-3caec4c4d9b72016.
940
Ridker, Paul M. et al. (2005), ‘A Randomized Trial of Low-Dose Aspirin in the Primary Prevention of Cardiovascular Disease in Women’, New England Journal of Medicine , 352, 1293–304.
941
Johannes, A. N. et al. (2011), ‘Aspirin for primary prevention of vascular events in women: individualized prediction of treatment effects’, European Heart Journal , 32:23, 2962–9.
942
Kruijsdijk, R. C. M. van et al. (2015), ‘Individualised prediction of alternateday aspirin treatment effects on the combined risk of cancer, cardiovascular disease and gastrointestinal bleeding in healthy women’, Heart , 101, 369–76.
943
Wu, J. et al. (2016), ‘Impact of initial hospital diagnosis on mortality for acute myocardial infarction: A national cohort study’, European Heart Journal , 7:2.
944
https://www.nytimes.com/2014/09/28/opinion/sunday/womens-atypical-heart-attacks.html?_r=0.
945
http://heart.bmj.com/content/102/14/1142.
946
Там же.
947
Yoon et al. (2014).
948
http://circ.ahajournals.org/content/133/9/916?sid=beb5f268-4205-4e62-be8f-3caec4c4d9b7.
949
https://www.england.nhs.uk/wp-content/uploads/2013/06/a09-cardi-prim-percutaneous.pdf.
950
https://www.hqip.org.uk/wp-content/uploads/2018/02/national-audit-of-percutaneous-coronary-intervention-annual-public-report.pdf.
951
https://www.sciencedaily.com/releases/2016/03/160304092233.htm, 2016, March.
952
http://heart.bmj.com/content/102/14/1142Опубликовано в сети 24 июня 2016 г.
953
https://www.sciencedaily.com/releases/2016/03/160304092233.htm, 2016, March.
954
Motiwala, Shweta R., Sarma, Amy, Januzzi, James L. and O’Donoghue, Michelle L. (2014), ‘Biomarkers in ACS and Heart Failure: Should Men and Women Be Interpreted Differently?’, Clinical Chemistry , 60:1.
955
‘Gender and Health Knowledge Agenda’, May 2015 (ZonMw, Netherlands).
956
https://www.leru.org/files/Gendered-Research-and-Innovation-Full-paper.pdf.
957
Там же.
958
‘Gender and Health Knowledge Agenda’, May 2015 (ZonMw, Netherlands).
959
Schiebinger, Londa (2014), ‘Gendered innovations: harnessing the creative power of sex and gender analysis to discover new ideas and develop new technologies’, Triple Helix , 1:9.
960
Dijkstra, A. F, Verdonk, P. and Lagro-Janssen, A. L. M. (2008), ‘Gender bias in medical textbooks: examples from coronary heart disease, depression, alcohol abuse and pharmacology’, Medical Education , 42:10, 1021–8; ‘Gender and Health Knowledge Agenda’, May 2015 (ZonMw, Netherlands); https://link.springer.com/article/10.1007/s10459-008-9100-z; Holdcroft (2007).
961
Sakalihasan, N., Limet, R. and Defawe, O. D. (2005), ‘Abdominal aortic aneurysm’, Lancet , 365, 1577–89.
962
‘Gender and Health Knowledge Agenda’, May 2015 (ZonMw, Netherlands).
963
http://genderedinnovations.stanford.edu/case-studies/colon.html#tabs-2.
964
Там же.
965
Там же.
966
http://www.wpro.who.int/topics/gender_issues/Takingsexandgenderintoaccount.pdf.
967
United Nations Development Programme (2015), Discussion Paper: Gender and Tuberculosis .
968
ACTION (Advocacy to Control TB Internationally), ‘Women and Tuberculosis: Taking a Look at a Neglected Issue’, ACTION, Washington DC, 2010.
969
Там же.
970
United Nations Development Programme (2015), Discussion Paper: Gender and Tuberculosis .
971
ACTION (Advocacy to Control TB Internationally), ‘Women and Tuberculosis: Taking a Look at a Neglected Issue’, ACTION, Washington DC, 2010.
972
Там же; United Nations Development Programme (2015), Discussion Paper: Gender and Tuberculosis .
973
ACTION (Advocacy to Control TB Internationally), ‘Women and Tuberculosis: Taking a Look at a Neglected Issue’, ACTION, Washington DC, 2010; United Nations Development Programme (2015), Discussion Paper: Gender and Tuberculosis .
974
http://www.wpro.who.int/topics/gender_issues/Takingsexandgenderintoaccount.pdf.
975
ACTION (Advocacy to Control TB Internationally), ‘Women and Tuberculosis: Taking a Look at a Neglected Issue’, ACTION, Washington DC, 2010.
976
United Nations Development Programme (2015), Discussion Paper: Gender and Tuberculosis .
977
ACTION (Advocacy to Control TB Internationally), ‘Women and Tuberculosis: Taking a Look at a Neglected Issue’, ACTION, Washington DC, 2010.
978
Schiebinger (2014).
979
http://genderedinnovations.stanford.edu/case-studies/hiv.html#tabs-2.
980
https://www.scientificamerican.com/article/autism-it-s-different-in-girls/.
981
https://www.um.edu.mt/library/oar/handle/123456789/15597.
982
https://www.scientificamerican.com/article/autism-it-s-different-in-girls/.
983
https://www.um.edu.mt/library/oar/handle/123456789/15597.
984
https://www.scientificamerican.com/article/autism-it-s-different-in-girls/.
985
. https://www.theguardian.com/society/2016/oct/21/m-in-the-middle-girls-autism-publish-novel-limpsfield-grange.
986
https://www.gov.uk/government/consultations/adult-autism-strategy-guidance-update.
987
https://www.theguardian.com/society/2016/oct/21/m-in-the-middle-girls-autism-publish-novel-limpsfield-grange.
Читать дальшеИнтервал:
Закладка: